Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial.

Nisha C DurandH G KimVishal N PatelMarion T TurnbullJason L SiegelDavid O HodgeRabih G TawkJames F MeschiaW David FreemanAbba C Zubair

Published in: Neurocritical care (2023)

Future larger randomized, placebo-controlled ICH studies are necessary to validate this study and establish the effectiveness of this therapeutic approach in the treatment of patients with ICH.

Keyphrases

placebo controlled
phase iii
double blind
open label
phase ii
study protocol
clinical trial
randomized controlled trial
mesenchymal stem cells
phase ii study
liver failure
brain injury
systematic review
respiratory failure
bone marrow
squamous cell carcinoma
case control
drug induced
radiation therapy